Clinical Trial Update: An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705 [Phase 1, Phase 2]

View source ↗

Summary

An extension study to evaluate the long-term safety and clinical activity of mRNA-3705 in participants previously enrolled in other Moderna trials for methylmal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methylmalonic Acidemia

Drugs mentioned

• mRNA-3705

Snippet

Sponsor: ModernaTX, Inc. | Conditions: Methylmalonic Acidemia | Phase 1, Phase 2 | Status: RECRUITING